The Banking and Strategy Initiative

Chillin' out till it needs to be funded

Tag Archives: Pfizer

The Mid-Week Trading Update: Earnings Season proves bulls right, Chicago PMI floors the pedals at a 65.9(V:US, MA:US, FB:US, TWTR:US, PFE:US, SNY:US, MRK:US, SSNGY:US)

Of course the recovery is capped as early earnings from Banks showed housing stepping into a mire and hoarding Cash still works for R&D rich Apple and Samsung. Caterpillar’s great … Continue reading

October 31, 2013

IT’s MoNDaY again! The Week Ahead (US Economy and Markets) on Monday Jun 03 – June 07, 2013: Anti Cancer after the big Diabetes push, Banks wink to a strong Q2

If you are still looking for Diabetes treatment led moves in the Pharma industry, the revolution has moved on, though Pfizer and Novartis seem not so surprisingly to have missed … Continue reading

June 3, 2013

Pfizer in advanced stages to sell off animal health and infant nutrition businesses | Deal Insight

Pfizer’s Animal health business has a 19% share of market and is so profitable that industry leader Bayer would have purchased it at a tad lower than $19 bln. However … Continue reading

February 19, 2012

US Economy: Newt Press monologues misfire in Florida, Chicago PMI up on new order data

The Chicago PMI came first in the morning as US House price data also reported weakness and the Chicago area PMI at 60 showed a significant lossses from a 63 … Continue reading

January 31, 2012 · 5 Comments

Coming up..Deals, Big Deals, Banks, Europe and Economics – Deal of the Day 2012?

Keeping the post ticker moving on a reading only day.. Onyx Pharma ONXX up for grabs, will Pfizer make a play for the blood cancer maker. What high premium mark? … Continue reading

December 1, 2011 · 2 Comments

Buffet spending his cash on Technology, Defence & Cash

While Buffet has already earned a nearly 20% on his IBM investment if he (likely) got in at near $162 in August when the stock turned back up, many revealing … Continue reading

November 15, 2011 · 1 Comment

The Big Pharma rebuilding "decade": Is Big Pharma ready for the competition?

Well frankly, after our efforts to read up and check the air pressure on the Big Pharma machines, we find the restructuring effort in each case expensive and not worth … Continue reading

April 19, 2011 · 2 Comments

After Pfizer and Merck, J&J gets up to go | Advantage Dealbook

J&J has seen better days especially with brand rebuilding taking up the better part of 2010 and Pfizer and Glaxo running away with the honors with a Genzyme bid and … Continue reading

April 17, 2011 · 1 Comment

The big pharma wannabes

Last year Glaxo Smithkline signed deals with Dynavax worth $810 million for “endosomal toll like receptors” for immune inflammatory diseases and $375mm with Supergen also of California for epigenetic targets … Continue reading

April 7, 2010 · 1 Comment